Alert: Major Price Advance (11/8/23)-Catalyst Biosciences Inc (NASDAQ: CBIO).


On 11/8/23, Catalyst Biosciences Inc (NASDAQ: CBIO) stock enjoyed a major increase of 14.3%, closing at $9.20. Relative to the market the stock has been exceptionally strong over the last nine months and has risen 36.7% during the last week.


Current PriceTarget Research Rating

With future capital returns forecasted to be below the cost of capital, CBIO is expected to be a major Value Eraser.

Catalyst Biosciences is currently unrated.

Rating Review

The stock is currently unrated.

Be the first to comment

Leave a Reply

Your email address will not be published.